UnityPoint’s Neoprobe Technology Enhances Cancer Surgery Outcomes by Lilu Anderson 26.06.2024 UnityPoint Health-Grinnell introduces Neoprobe Gamma Detection for precise breast cancer surgery, enhancing patient care and personalized treatment.
Lilly’s Zepbound Resolves Sleep Apnea in 52% of Patients by Mark Eisenberg 22.06.2024 Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
Zealand Pharma Surges on Promising Weight Loss Drug Trial Results by Mark Eisenberg 21.06.2024 Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...
Novo Nordisk CEO to Testify on High Prices of Ozempic, Wegovy by Mark Eisenberg 15.06.2024 Senate subpoenas Novo's Langa over drug pricing; Jorgensen to testify in September as Novo blames U.S. health system for high ...
Pfizer’s Debt Concerns Cast Doubt on Viking Therapeutics Acquisition by Mark Eisenberg 01.04.2024 Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...
UK Pharma Complaints Delay: Public Health at Risk? by Mark Eisenberg 19.02.2024 Investigation reveals significant delays in processing complaints against UK drug companies, raising concerns about patient safety and public health. Increased ...
New Tech Tracks Brain Cells’ Off Switches by Lilu Anderson 23.01.2024 Scientists at Scripps Research have developed a breakthrough technology that allows them to track when brain cells shut off, providing ...
Wall Street Analyzes Eli Lilly’s Promising Outlook by Terry Bingman 22.01.2024 Discover the promising future for investors in Eli Lilly and Company (NYSE: LLY), a leader in the biopharmaceutical industry, with ...